EBF short interest

Ennis · settlement of Oct 30, 2026

As of Oct 30, 2026, 1.9M EBF shares were sold short, down 1.0% from the Oct 15, 2026 count. At the stock's average daily volume, that is 13 days to cover.

Ennis research · EBF trades by Congress · Short interest movers · Most shorted stocks · Source

Shares sold short
1.9M1,856,387
Change
−1.0%from 1.9M
Of shares outstanding
7.33%#1,138 of 3,711 stocks measured
Days to cover
13at the average daily volume
Average daily volume
142,153shares, as FINRA reports it
Most in 16 settlements
2.3MSep 15, 2026

Every settlement

16 settlements, newest first
SettlementShares shortChangeAvg daily volumeDays to cover
Oct 30, 20261,856,387−1.0%142,15313
Oct 15, 20261,874,458−10.8%162,19312
Sep 30, 20262,100,875−10.3%206,80910
Sep 15, 20262,341,305+5.6%134,89817
Aug 31, 20262,217,410+9.8%182,78112
Aug 14, 20262,018,669+9.4%132,82215
Jul 31, 20261,845,960+5.4%112,85316
Jul 15, 20261,750,724+11.2%137,16513
Jun 30, 20261,574,827+18.4%242,9856.5
Jun 15, 20261,329,885+3.2%115,61512
May 29, 20261,288,698−1.8%128,33810
May 15, 20261,311,975+0.3%168,6257.8
Apr 30, 20261,308,170+7.8%197,6206.6
Apr 15, 20261,213,951−7.5%117,90610
Mar 31, 20261,312,956−11.2%203,4276.5
Mar 13, 20261,478,196—142,76210

Source

Short interest is the number of shares sold short and not yet bought back. Brokers report it to FINRA for two settlement dates a month, the middle and the end, and FINRA publishes each count about a week later. It is not a daily figure: between settlements no one publishes a count. Days to cover is the short interest divided by the average daily volume FINRA reports beside it. A rising count is shown in red and a falling one in green.

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.